RecruitingNCT06709833

Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation


Sponsor

University Hospital Tuebingen

Enrollment

100 participants

Start Date

Dec 16, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Despite being generally benign tumors, meningiomas are associated with an increased risk for thrombembolic complications after surgical resection. The molecular mechanisms underlying this circumstance are still unknown. In this prospective observational trial, the investigators aim to evaluate the changes in coagulation and platelet function caused by tumor resection. Blood samples are obtained by patients undergoing meningioma resection before and immediately after resection to detect said changes. As a control cohort, blood samples are obtained from patients undergoing resection for glioma.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients undergoing resection for meningioma or
  • Patients undergoing resection for glioma or
  • Healthy controls
  • written consent for study participation

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital for Anaesthesiology and Intensive Care Medicine, Tuebingen

Tübingen, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06709833


Related Trials